| scholarly article | Q13442814 |
| P50 | author | Hala Darwish | Q42792425 |
| Hani Tamim | Q76572305 | ||
| P2093 | author name string | Stephanie Ghassan | |
| Bassem Yamout | |||
| Samia Khoury | |||
| Sahar Osman | |||
| Ribal Haddad | |||
| P2860 | cites work | Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors | Q22252931 |
| Vitamin D, cognition, and dementia: A systematic review and meta-analysis | Q22306178 | ||
| Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain | Q24320314 | ||
| Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria | Q24605493 | ||
| Cognitive changes in multiple sclerosis | Q33377548 | ||
| Saudi normative data for the Wisconsin Card Sorting test, Stroop test, Test of Non-verbal Intelligence-3, Picture Completion and Vocabulary (subtest of the Wechsler Adult Intelligence Scale-Revised). | Q33785669 | ||
| Vitamin D and cognitive impairment in the elderly U.S. population. | Q34447594 | ||
| Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis | Q34923586 | ||
| 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. | Q35192119 | ||
| Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings | Q35475021 | ||
| A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients | Q35809567 | ||
| Serum 25-hydroxyvitamin D predicts cognitive performance in adults | Q36015841 | ||
| Total vitamin D assay comparison of the Roche Diagnostics "Vitamin D total" electrochemiluminescence protein binding assay with the Chromsystems HPLC method in a population with both D2 and D3 forms of vitamin D. | Q36994032 | ||
| The role of processing speed in the Brief Visuospatial Memory Test - revised | Q37093099 | ||
| Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature | Q37122047 | ||
| Serum 25-hydroxyvitamin D concentration and cognitive impairment. | Q37316095 | ||
| Vitamin D as an early predictor of multiple sclerosis activity and progression | Q37723877 | ||
| Vitamin D in the healthy and inflamed central nervous system: access and function | Q37921501 | ||
| Treatment of cognitive impairment in multiple sclerosis: position paper | Q38062466 | ||
| 'Vitamin D and cognition in older adults': updated international recommendations. | Q38226308 | ||
| Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial | Q38398910 | ||
| Montreal Cognitive Assessment Arabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. | Q39378562 | ||
| Immunomodulatory effects of Vitamin D in multiple sclerosis | Q39868289 | ||
| Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b | Q40441547 | ||
| Risk factors for multiple sclerosis and associations with anti-EBV antibody titers. | Q42152827 | ||
| Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. | Q43866034 | ||
| Increased anxiety in mice lacking vitamin D receptor gene | Q44913806 | ||
| Donepezil improved memory in multiple sclerosis in a randomized clinical trial | Q45144727 | ||
| Immunomodulation by vitamin D in multiple sclerosis: More than IL-17. | Q50539594 | ||
| Intracellular distribution of the vitamin D receptor in the brain: comparison with classic target tissues and redistribution with development. | Q50656151 | ||
| Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. | Q50931184 | ||
| Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. | Q51995485 | ||
| Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age. | Q52005424 | ||
| Vitamin D in MS: A vitamin for 4 seasons | Q57913686 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| vitamin D | Q175621 | ||
| vitamin | Q34956 | ||
| P304 | page(s) | 45926 | |
| P577 | publication date | 2017-04-04 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients | |
| P478 | volume | 7 |
| Q92817653 | NRF2 as a Therapeutic Target in Neurodegenerative Diseases |
| Q47565684 | Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial |
| Q47306228 | Vitamin D and Multiple Sclerosis: A Comprehensive Review |
| Q90672687 | Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact |
Search more.